DePuy Synthes Spine launches new allograft implant

1009

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, has announced the US launch of its Conform Sheet. The company reports that the new allograft implant is a hydrated, pliable and totally demineralised cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation.

According to a press release, Conform Sheet (processed by the Musculoskeletal Transplant Foundation) has both osteoinductive and osteoconductive properties. The press release reports that through a unique demineralisation process, bone morphogenic proteins are exposed—providing the product with its osteoinductive properties while the cancellous structure of the scaffold provides its osteoconductive characteristics.

Conform Sheet is offered in four sizes, which may be cut to accommodate irregular shaped anatomy. The implant may be used with DePuy Synthes Spine Matrix minimally invasive pedicel screw system and Expedium spine system as well as other systems for spinal fusion.

“Conform Sheet has excellent handling characteristics. It is compressible for precise placement, where it can then expand to fill the bone void,” says Khalid Sethi, chief of Neurosurgery at United Health Services Wilson Medical Center in Johnson City, USA. “It is packaged in a hydrated state, which eliminates the need for rehydration and there is no implant migration upon irrigation.”